September 1, 2022 Dan Schell, Editor Mathematician Alan Turing changed history in 1950 with a simple question: “Can machines think?” The phrase artificial intelligence (AI) was coined in 1956, yet the pharmaceutical industry embraced artificial intelligence and machine learning (ML) only about 15 to 20 years ago as a technology for use in drug discovery and drug development. It is critical to move beyond simply using AI as a buzzword and instead determine if AI/ML does indeed change the...

June 27, 2022 Anna-Marie MacDonald , Editor According to a recent report , startups developed 65% of the total drug development pipeline. And 42% of the products filed with the FDA. That creates huge opportunities for investors but also has the potential for enormous risk. Research and development of a new drug can take years and, in some cases decades. In the end, there is no guarantee the product gains FDA approval and makes it to market. When considering an investment in a startup...

Comprehensive strategies to save time and reduce cost in end-to-end clinical development June 14, 2022 Karen Langhauser, Editor Bringing innovation to patients is no small task and a journey with many challenges. Despite the disruption caused by the COVID-19 pandemic, the total number of products in active development globally exceeds 6,000, across a wide range of disease areas . One measure of clinical development productivity involves relating molecule success rates to the complexity and...